Literature DB >> 19352348

Pharma swept up in biogenerics gold rush.

Mark Ratner.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19352348     DOI： 10.1038/nbt0409-299

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Merck joins the biotech game.

Authors:  Victor Bethencourt
Journal:  Nat Biotechnol       Date:  2009-02       Impact factor: 54.908
  1 in total
  4 in total

1.  India's Cipla sets sights on Avastin, Herceptin and Enbrel.

Authors:  Killugudi Jayaraman
Journal:  Nat Biotechnol       Date:  2010-09       Impact factor: 54.908

2.  Appetite for cheaper biologics spreads across the map.

Authors:  Melanie Senior
Journal:  Nat Biotechnol       Date:  2013-12       Impact factor: 54.908

3.  Biosimilars encircle Rituxan, US debates innovator exclusivity.

Authors:  Karen Carey
Journal:  Nat Biotechnol       Date:  2011-03       Impact factor: 54.908

4.  Genome sequence of the recombinant protein production host Pichia pastoris.

Authors:  Kristof De Schutter; Yao-Cheng Lin; Petra Tiels; Annelies Van Hecke; Sascha Glinka; Jacqueline Weber-Lehmann; Pierre Rouzé; Yves Van de Peer; Nico Callewaert
Journal:  Nat Biotechnol       Date:  2009-05-24       Impact factor: 54.908
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.